Abstract

Background: A rare form of hypoglycemia called insulin autoimmune syndrome (IAS) occurs when someone who has never been exposed to endogenous insulin develops insulin auto antibodies. As far as our knowledge goes, only 30 cases have been reported in India. Here we report one case of insulin autoimmune syndrome diagnosed and managed in our hospital.

Case Presentation: We present a case of a 68 year-old male who presented with recurrent episodes of post-prandial hypoglycemia. On biochemical evaluation, he was found to have hyper insulinaemic hypoglycemia. Localization studies with CT abdomen were negative for insulinoma. The diagnosis was confirmed by elevated blood levels of insulin auto antibodies. The patient was treated with frequent low carbohydrate meals and high dose corticosteroids. The patient’s condition improved, and able to maintain euglycemia on a low dose of corticosteroids.

Conclusion: IAS is a rare endogenous cause of hyper insulinaemic hypoglycemia. It should be suspected in patients presenting with post prandial hypoglycemia, with high insulin and C peptide levels.

• 1.   Hirata Y, Ishizu H, Ouchi N, et al. Insulin autoimmunity in a case of spontaneous hypoglycaemia. J Jpn Diabetes Soc. 1970;13:312-320.
• 2.   Patel M, Shah R, Ramteke Jadhav S, et al. Management of insulin autoimmune hypoglycaemia: Single centre experience from Western India with systematic review of world literature. Clin Endocrinol (Oxf). 2020;92:409-420.
• 3.   Raizada N, Rahaman SH, Kandasamy D, Jyotsna VP. Rare association of insulin autoimmune syndrome with ankylosing spondylitis. Endocrinol Diabetes Metab Case Rep. 2015;2015:150090.
• 4.   Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract. 2009;83:e19-20.
• 5.   Wong SL, Priestman A, Holmes DT. Recurrent hypoglycemia from insulin autoimmune syndrome. J Gen Intern Med. 2014;29:250-254.
• 6.   Ismail AA. Testing for insulin antibodies is mandatory in the differential diagnosis of hypoglycemia in nondiabetic subjects. Clin Endocrinol (Oxf). 2012;76:603-604.
• 7.   Lebowitz MR, Blumenthal SA. The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med. 1993;153:650-655.
• 8.   Woo C-Y, Jeong JY, Jang JE, et al. Clinical features and causes of endogenous hyperinsulinemic hypoglycemia in Korea. Diabetes Metab J. 2015;39:126-131.
• 9.   Schlemper R, Uchigata Y, Frolich M, et al. Recurrent hypoglycemia caused by the insulin autoimmune syndrome: the first Dutch case. Neth J Med. 1996;48:188-192.
• 10.   Saxon DR, McDermott MT, Michels AW. Novel management of insulin autoimmune syndrome with rituximab and continuous glucose monitoring. J Clin Endocrinol Metab. 2016;101:1931-1934.

Data Sharing Statement

Funding